329014-60-0 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Difluoro-4-methoxybenzoic acid serves as a crucial building block in the synthesis of a range of pharmaceutical products. It is used as an intermediate for the development of drugs due to its ability to contribute to the formation of biologically active compounds, enhancing the therapeutic potential of medications.
Used in Agrochemical Industry:
In the agrochemical sector, 2,3-Difluoro-4-methoxybenzoic acid is employed as a precursor in the production of various agrochemicals. It is used as a starting material for synthesizing compounds that possess pesticidal or herbicidal properties, thereby contributing to crop protection and yield enhancement.
It is imperative to handle 2,3-Difluoro-4-methoxybenzoic acid with caution, as it can pose health risks if ingested or inhaled. Adequate safety measures, including the use of personal protective equipment and adherence to proper laboratory protocols, are essential when working with 2,3-Difluoro-4-methoxybenzoic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 329014-60-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,9,0,1 and 4 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 329014-60:
(8*3)+(7*2)+(6*9)+(5*0)+(4*1)+(3*4)+(2*6)+(1*0)=120
120 % 10 = 0
So 329014-60-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H6F2O3/c1-13-5-3-2-4(8(11)12)6(9)7(5)10/h2-3H,1H3,(H,11,12)
329014-60-0Relevant articles and documents
Prodrug substituted benzoxazoles as estrogenic agents
-
Page/Page column 29, (2010/10/20)
This invention provides estrogen receptor modulators of formula I, having the structure wherein Q, Q2, R1, R2, R2a, R3, R3a, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
Substituted benzoxazoles as estrogenic agents
-
, (2008/06/13)
This invention provides estrogen receptor modulators of formula I, having the structure wherein R1, R2, R2a, R3, R3a, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
